- Home
- CLSD vs NCSM Comparison
CLSD vs NCSM Comparison
Compare CLSD & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- NCSM
- Stock Information
- Founded
- CLSD 2011
- NCSM 2006
- Country
- CLSD United States
- NCSM United States
- Employees
- CLSD N/A
- NCSM N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- CLSD Health Care
- NCSM Energy
- Exchange
- CLSD Nasdaq
- NCSM Nasdaq
- Market Cap
- CLSD 68.4M
- NCSM 76.3M
- IPO Year
- CLSD 2016
- NCSM 2017
- Fundamental
- Price
- CLSD $4.37
- NCSM $42.59
- Analyst Decision
- CLSD Hold
- NCSM
- Analyst Count
- CLSD 4
- NCSM 0
- Target Price
- CLSD $65.00
- NCSM N/A
- AVG Volume (30 Days)
- CLSD 78.5K
- NCSM 19.7K
- Earning Date
- CLSD 11-11-2025
- NCSM 10-29-2025
- Dividend Yield
- CLSD N/A
- NCSM N/A
- EPS Growth
- CLSD N/A
- NCSM N/A
- EPS
- CLSD N/A
- NCSM 4.71
- Revenue
- CLSD $4,166,000.00
- NCSM $175,468,000.00
- Revenue This Year
- CLSD $98.20
- NCSM $11.91
- Revenue Next Year
- CLSD $213.77
- NCSM $7.63
- P/E Ratio
- CLSD N/A
- NCSM $9.04
- Revenue Growth
- CLSD N/A
- NCSM 19.31
- 52 Week Low
- CLSD $3.32
- NCSM $16.81
- 52 Week High
- CLSD $24.75
- NCSM $53.69
- Technical
- Relative Strength Index (RSI)
- CLSD 45.81
- NCSM 41.88
- Support Level
- CLSD $4.00
- NCSM $48.85
- Resistance Level
- CLSD $4.45
- NCSM $52.06
- Average True Range (ATR)
- CLSD 0.40
- NCSM 3.13
- MACD
- CLSD 0.13
- NCSM -1.04
- Stochastic Oscillator
- CLSD 83.87
- NCSM 4.64
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.